Compounds > sdz 220-581
Page last updated: 2024-09-03

sdz 220-581 and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid

sdz 220-581 has been researched along with 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid in 1 studies

Compound Research Comparison

Studies
(sdz 220-581)		Trials
(sdz 220-581)		Recent Studies (post-2010)
(sdz 220-581)		Studies
(3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid)		Trials
(3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid)		Recent Studies (post-2010) (3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid)
110511724

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bakshi, VP; Geyer, MA; Lehmann-Masten, V; Neijt, HC; Tricklebank, M1

Other Studies

1 other study(ies) available for sdz 220-581 and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid

ArticleYear
Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 288, Issue:2

    Topics: Animals; Antipsychotic Agents; Behavior, Animal; Binding, Competitive; Biphenyl Compounds; Drug Interactions; Excitatory Amino Acid Antagonists; Hyperkinesis; Male; Motor Activity; Piperazines; Propionates; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reflex, Startle

1999